About
Rapid Sepsis Diagnostic Device
Areas of Focus
Categories
DiagnosticsMedical Measurement
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
11
As Collaborator
2
Total Enrollment
1,923
By Phase
PHASE2: 1PHASE1: 2NA: 1
By Status
COMPLETED: 10WITHDRAWN: 2RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05849935Lead Sponsor
abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003
N/ACompleted
61 participants
Started: Jul 17, 2023 · Completed: Jul 31, 2023
NCT05541822Lead Sponsor
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
PHASE2Recruiting
178 participants
Started: Jan 17, 2023 · Completed: Feb 28, 2029
NCT05596032Lead Sponsor
Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2
N/ACompleted
440 participants
Started: Oct 23, 2022 · Completed: Feb 1, 2023
NCT05627076Lead Sponsor
Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.
N/ACompleted
46 participants
Started: Aug 29, 2022 · Completed: Oct 31, 2022
NCT05248074Lead Sponsor
To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers
PHASE1Completed
25 participants
Started: Jan 4, 2022 · Completed: Oct 18, 2022
Locations (1)
Headquarters
Epalinges, Switzerland
Map
Loading map...